Transient Hemiageusia in Cerebrovascular Lateral Pontine Lesions
JNNP 77:680-683, Landis,B.N.,et al, 2006
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006
International Study on Low-Grade Primary Central Nervous System Lymphoma
Ann Neurol 59:755-762, Jahnke,K.,et al, 2006
Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006
Is IV Tissue Plasminogen Activator Beneficial in Patients With Hyperdense Artery Sign?
Neurol 66:1171-1174, Qureshi,A.I.,et al, 2006
MR Diffusion-Weighted Imaging and Outcome Prediction After Ischemic Stroke
Neurol 66:1159-1163, Hand,P.J.,et al, 2006
Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006
MRI T2 Lesion Burden in Multiple Sclerosis. A Plateauing Relationship with Clinical Disability.
Neurol 66:1384-1389, Li,D.K.B.,et al, 2006
Neuropathy Progressing to Myeloneuropathy 20 Years After Partial Gastrectomy
Neurol 66:1451, Everett,C.M.,et al, 2006
Multiple Sclerosis: New Insights and Trends
AJNR 27:954-957, Inglese,M., 2006
CT and MR Imaging of Neuroaxonal Leukodystrophy Presenting as Early-Onset Frontal Dementia
AJNR 27:1037-1039, Mascalchi,M.,et al, 2006
Neuropathology of the Neuroradiologist: Rosenthal Fibers
AJNR 27:958-961, Wippold,F., II,et al, 2006
Gadolinium Enhancement of Cauda Equina: A New MR Imaging Finding in the Radiculitic Form of Tick-Borne Encephalitis
AJNR 27:995-997, Marjelund,S.,et al, 2006
Diffusion MRI Abnormalities After Prolonged Febrile Seizures with Encephalopathy
Neurol 66:1304-1309, Takanashi,J.,et al, 2006
Past Adult Lead Exposure is Linked to Neurodegeneration Measured by Brain MRI
Neurol 66:1476-1484,1464, Stewart,W.F.,et al, 2006
Revised Diagnostic Criteria for Neuromyelitis Optica
Neurol 66:1485-1489, Wingerchuk,D.M.,et al, 2006
Acute Longitudinal Myelitis as the initial Manifestation of Sjgerns Syndrome
JNNP 77:780, Yamamoto,T.,et al, 2006
Accuracy of Magnetic Resonance Imaging for the Diagnosis of Multiple Sclerosis: Systematic Review
BMJ 332:875-878, Whiting P.,et al, 2006
Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006
Persistent Infarct Hyperintensity on Diffusion-Weighted Imaging Late After Stroke Indicates Heterogeneous, Delayed, Infarct Evolution
Stroke 37:1418-1423, Rivers,C.S.,et al, 2006
Cerebral Microhemorrhage
Stroke 37:550-555, Viswanathan,A. &Chabriat,H., 2006
Metabolic Syndrome as an Independent Risk Factor of Silent Brain Infarction in Healthy People
Stroke 37:466-470, Kwon,H.-M.,et al, 2006
The Hyperdense Posterior Cerebral Artery Sign
Stroke 37:399-403, Krings,T.,et al, 2006
Accuracy of Color Duplex Ultrasound Diagnosis of Spontaneous Carotid Dissection Causing Ischemia
Stroke 37:377-381, Benninger,D.H.,et al, 2006
Recent Advances in the Diagnosis and Management of Migraine
BMJ 332:25-29, Goadsby,P.J., 2006
Cerebral Microbleeds on MRI
Neurol 66:165-171, Koennecke,H.-C., 2006
Quantification of Carotid Stenosis on CT Angiography
AJNR 27:13-19, Bartlett,E.S.,et al, 2006
Contribution of Diffusion-Weighted Imaging in Determination of Stroke Etiology
AJNR 27:35-39, Wessels,T.,et al, 2006
MR IMaging and Angiography of Primary CNS Vasculitis of Childhood
AJNR 27:192-199, Aviv,R.I.,et al, 2006
Sequential MR Imaging Changes in Nonketotic Hyperglycinemia
AJNR 27:208-211, Mourmans,J.,et al, 2006
Leukoencephalopathy, Cerebral Calcifications, and Cysts
AJNR 27:200-203, Sener,U.,et al, 2006
Severe Hypoglycemia and Vulnerability of the Brain
Arch Neurol 63:138, Cho,S.-J.,et al, 2006
Cerebellar Infarction int he Territory of the Medial Branch of the Superior Cerebellar Artery
Neurol 66:115-117, Sohn,S.-I.,et al, 2006
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006
Gray and White Matter Brain Atrophy and Neuropsychological Impairment in Multiple Sclerosis
Neurol 66:685-692, Sanfilipo,M.P.,et al, 2006
Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006
Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006
Intracranial Dural Arteriovenous Fistulas with Retrograde Cortical Venous Drainage: Assessment with Cerebral Blood Volume by Dynamic Susceptibility Contrast Magnetic Resonance Imaging
AJNR 27:1252-1256,1257, Noguchi,K.,et al, 2006
Multiple Sclerosis: The Role of MR Imaging
AJNR 27:1165-1176, Ge,Y., 2006
Amebic Meningoencepahlitis: Spectrum of Imaging Findings
AJNR 27:1217-1221, Singh,P.,et al, 2006
Diffusion-Weighted MR Imaging in Early Diagnosis and Prognosis of Hypoglycemia
AJNR 27:1222-1224, Lo,L.,et al, 2006
MR Imaging and Prognosis of Hypoxic-Ischemic Leukoencephalopathy
Neurocrit Care 4:119-126, Finelli,P. &DiMario,F.J. Jr., 2006
A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006
Nonaneurysmal Convexity Subarachnoid Hemorrhage
Neurocrit Care 4:229-233, Patel,K.C. &Finelli,P.F., 2006
Atypical Appearance of a Primary Central Nervous System Lymphoma
Arch Neurol 63:908-909, Trendelenburg,G.,et al, 2006
Voltage-gated Potassium Channel Antibody-Associated Encephalitis with Basal Ganglia Lesions
Neurol 66:1780-1781, Hiraga,A.,et al, 2006
Primary Dural Lymphomas: A Clinicopathologic Study of Treatment and Outcome in Eight Patients
Neurol 66:1763-1765, Iwamoto,F.M.,et al, 2006